Herbalife Reaffirms Third Quarter and Full Year 2026 Guidance
Company Continues to Expect Net Sales Growth for the Third Quarter and Full Year; Reaffirms Adjusted EBITDA¹ Outlook
LOS ANGELES, August 31, 2026--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today reaffirmed the third quarter and full-year 2026 financial guidance it provided on August 5, 2026 in connection with its second quarter 2026 earnings release.
The Company continues to expect year-over-year net sales growth for both the third quarter and the full year 2026, on a reported and constant currency basis2, and reaffirms its adjusted EBITDA1 guidance for both periods. The Company's guidance assumptions, including foreign exchange rates, are unchanged from those disclosed on August 5, 2026.
"Our outlook for the remainder of the year remains firmly on track, and we are reaffirming the third quarter and full-year guidance we provided last month," said John DeSimone, Chief Financial Officer. "Our outlook is consistent with the expectations we shared, and we remain confident in our ability to deliver a fifth consecutive quarter of year-over-year net sales growth and continued momentum across the remainder of 2026."
Outlook
Third Quarter 2026 Guidance - Reaffirmed
| $ million | Net Sales | Adjusted EBITDA1 | CapEx |
| Reported | +0.5% to +4.5% YoY | 160 – 180 | 15 – 25 |
| Constant Currency(a) | +1.5% to +5.5% YoY | 165 – 185 | |
| Q3 '25 Actuals | 1,273.7 | 163.0 12.8% margin | 20.8 |
Full-Year 2026 Guidance – Reaffirmed
| $ million | Net Sales | Adjusted EBITDA1 | CapEx |
| Reported | +2.5% to +5.5% YoY | 670 – 690 | 50 – 70 |
| Constant Currency(a) | +2.5% to +5.5% YoY | 690 – 710 | |
| FY '25 Actuals | 5,037.5 | 657.6 13.1% margin | 80.4 |
| (a) | Non-GAAP Measure. Represents projections using U.S. dollars at Q3 '25 and FY '25 average FX rates, respectively, and adjusting for other FX related impacts. Refer to Schedule A – "Non-GAAP Financial Measures" for a discussion of why the Company believes adjusting for the effects of foreign exchange is useful and non-GAAP guidance. |
| 1 | Non-GAAP measure. Refer to Schedule A – "Non-GAAP Financial Measures" for a discussion of why the Company believes these non-GAAP measures are useful and certain information regarding non-GAAP guidance. |
| 2 | Non-GAAP measure. Refer to Schedule A – "Non-GAAP Financial Measures" for a discussion of why the Company believes adjusting for the effects of foreign exchange is useful. |
Guidance Assumptions
Net sales and adjusted EBITDA1 use the average daily exchange rates for the first two weeks of July 2026 to translate local currency projections
Additional FY 2026 Expectations - Reaffirmed